International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 18: [Related article:] 814-821, 2019; DOI: 10.3892/ol.2019.10342
Subsequently to the publication of this article, the authors have realized that the article contained several errors that were not corrected. First, an error was introduced into Fig. 1; essentially, the mutation of T>C at position 794 of the nucleotide sequence of the wild-type MYD88 plasmid was not portrayed correctly (as cytosine) in panel (B). In addition, the sequencing result in the lowest panel of Fig. 4 shows the wild-type sequence, and therefore the nucleotide at position 794 should have been presented as T, not as C. Corrected versions of Figs. 1 and 4 are shown opposite.
Otherwise, textual errors remained in the paper. Some textual errors were featured in the subsection of the Materials and methods entitled “Sensitivity evaluation by HRM assay and direct sequencing”, in the final paragraph in the right-hand column of p. 816. The sentence commencing 6 lines from the bottom of the page should have read as: “The melting curve obtained using 1% negative control template clearly differed from the positive template.” (“negative control” instead of “mutated”, and “positive” instead of “negative”). The subsequent sentence should have read as: “However, the mutation was detectable by direct sequencing when the negative control template frequency was >10% (Fig. 4).” (“negative control template” instead of “mutant”). Finally, some errors remained uncorrected in the legend for Fig. 4 on p. 819. The first sentence in the legend should have read as follows: “Direct sequencing results of negative control template at serial dilutions (100, 50, 20, 10, 5, 1 and 0%) with positive control.” (“negative control template” instead of “MYD88 p.L265P mutations”, and “positive” instead of “negative”).
The authors and the Editor apologize to the readership of the Journal for any inconvenience caused.